Thursday , December 8 2016

From the Editor

December, 2016

  • 8 December

    Dec. 8, 2016

    dave

    It has been 10 years since Sitagliptin was approved by the FDA. When it was first approved there was a lot of pushback from prescribers to trying a new class, as the last class, the TZDs, had suffered through the problems with Rezulin and the cardiovascular problems associated with Actos ...

    Read More »

Latest Articles

December, 2016

Test Your Knowledge

December 3, 2016

This injectable drug class focuses on the incretin system and leads to increased insulin secretion, decreased glucagon secretion, and slowed gastric emptying. One of its advantages is that its use can lead to weight loss:

Correct

Answer: 1. GLP-1 receptor agonists

Diabetes Care 2011 May; 34(Supplement 2): S279-S284. http://dx.doi.org/10.2337/dc11-s231

Incorrect

More Articles

December, 2016

November, 2016

  • 29 November

    When Patients Cannot Afford Insulin

    iStock_000062147826_Small

    Laurie Klipfel, RN, MSN, BC-ANP, CDE was recently asked if she could offer any pearls of wisdom for another Disaster Averted regarding a patient with type 1 diabetes who couldn't afford his analog insulin. After reading her advice, keep reading to learn how you can take action to help make insulin more affordable.

    Read More »
  • 29 November

    Dr. Jeffrey Mechanick Part 5, Tips to Alter Lifestyle

    Jeffrey Mechanick

    Dr. Jeffrey Mechanick talks with Diabetes in Control Publisher Steve Freed at the 2016 AACE Meeting. In part 5 of this Exclusive Interview, Dr. Mechanick explains how he helps patients determine ways to improve their lifestyle.

    Read More »
  • 29 November

    Continuous Glucose Monitoring in the Hospital Part 4

    Hospital room interior

    In this week's Homerun Slides, blood-based glucose sensors vs. subcutaneous CGM sensors.

    Read More »
  • 29 November

    International Textbook of Diabetes Mellitus, 4th Ed., Excerpt #52: Incretin Physiology in Health and Disease Part 2 of 6

    DeFronzoCover

    Secretion of incretin hormones: The mucosa of the intestinal tract harbors a large number of endocrine cells that give rise to various peptide hormones. These include cholecystokinin, motilin, secretin, gastrin, gastric inhibitory polypeptide (GIP, also referred to as glucose-dependent insulinotropic polypeptide), glucagon-like peptide 1 (GLP-1), glucagon-like peptide 2, and peptide YY.

    Read More »
  • 26 November

    Survey Says: Top Polls of 2016

    Smiling charity worker at the door

    In a year that saw much discussion about new drugs, new devices, and how politics might affect medical care, the surveys you were most interested in were those that touched on the core aspects of care for patients with diabetes. See the five polls that engaged you most.

    Read More »
  • 26 November

    Responding to Surveys

    iStock_000075170267_Small

    Why do you respond to DIC survey questions? 1. Because the question is interesting 2. Want to share my opinion 3. Want to see what my colleagues think 4. All of the above 5. I usually don't respond

    Read More »
  • 22 November

    Some Blood Glucose Number is Better than No Number

    SONY DSC

    In my experience, most people will check their fasting glucose levels, but due to time, place, not enough strips, or just the fact they don’t want to see…many will not check after eating. For those who will only check once a day, I recommend alternating a fasting blood glucose check with a bedtime blood glucose check.

    Read More »